Slideshow

New FDA Warning

Author(s):

James Phelps, MD

A rare but serious reaction to this treatment can have immunological consequences. As with all medications, however, the latest alert does not change how psychiatrists manage the risks.

Related Videos
journey
Related Content
Bipolar Awakenings
November 21st 2024

Bipolar Awakenings: The Quest to Heal Bipolar Disorder

John Calvin Chatlos, MD
Blue Light, Depression, and Bipolar Disorder
August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
questions
November 12th 2024

Differential Diagnosis of Mixed States is Nearly Impossible. Here’s How to Cope.

James Phelps, MD
Four Myths About Lamotrigine
August 3rd 2021

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar
November 4th 2024

SAINT iTBS Protocol Shows Promise for Bipolar I Depression

Kenneth J. Bender, PharmD, MA
older woman
October 22nd 2024

Don't Fear Older Medications and Treatments for Our Senior Patients

Elizabeth A. Varas, MD
© 2024 MJH Life Sciences

All rights reserved.